XML 98 R44.htm IDEA: XBRL DOCUMENT v3.20.1
PREPAYMENTS AND OTHER CURRENT ASSETS (Tables)
12 Months Ended
Dec. 31, 2019
PREPAYMENTS AND OTHER CURRENT ASSETS  
Schedule of Prepayments and Other Current Assets

Prepayments and other current assets consist of the following:

 

 

 

 

 

 

 

 

 

 

 

 

As at December 31, 

 

 

Notes

 

2018

 

2019

 

2019

 

    

 

    

RMB

    

RMB

    

US$

Due from suppliers

 

i)

 

10,751

 

5,957

 

856

Due from hospitals

 

ii)

 

576

 

406

 

58

Loan receivables

 

iii)

 

151,139

 

70,077

 

10,066

Advances to employees

 

iv)

 

1,056

 

4,271

 

614

Receivables from disposal of medical equipment

 

v)

 

69,410

 

120

 

17

Deferred expenses

 

  

 

50

 

 —

 

 —

Interest receivable

 

  

 

3,680

 

2,891

 

415

Dividend receivable

 

  

 

766

 

766

 

110

Tax refund

 

vi)

 

 —

 

14,466

 

2,078

Others

 

 

 

5,084

 

4,927

 

708

 

 

 

 

242,512

 

103,881

 

14,922

 

 

 

 

 

 

 

 

 

Allowance for doubtful debts

 

  

 

(14,798)

 

(9,013)

 

(1,295)

 

 

 

 

 

 

 

 

 

 

 

 

 

227,714

 

94,868

 

13,627

 

The Group records allowance for doubtful debts in “general and administrative expenses” in the consolidated statements of comprehensive loss.

i)

Amounts due from suppliers represented prepayments made for orders and returnable deposits of cancelled orders. The risk of loss arising from non-performance by or bankruptcy of suppliers is assessed prior to the order of the equipment. The Group has provided reserve for bad debt amounting to RMB4,798 and nil on the amounts due from suppliers as at December 31, 2018 and 2019, respectively.

ii)

Amounts due from hospitals represented interest-free advances to hospitals and the compensation to be received from hospitals for early termination. The Group has assessed the impact of such advances on revenue recognition at the outset of the arrangement and has concluded that they do not affect revenue recognition. The risk of loss arising from any failure of hospital customers to fulfill their financial obligations is assessed prior to making the advances and is monitored for recoverability on a regular basis by management.

iii)

Loan receivables represented the loans to other parties, including loans to related parties such as the Xi’an JiangyuanAndike Ltd. (“JYADK”) and Beijing Allcure Medical Information Technology Co., Ltd. (“Allcure Information”) of total amount of RMB15,118 and RMB12,173 (US$1,749) as at December 31, 2018 and 2019, and third parties of RMB136,021 and RMB57,904(US$8,317) as at December 31, 2018 and 2019, respectively. The Group recorded allowance for doubtful debts amounting to RMB10,000  and RMB9,000 (US$1,293) as of December 31, 2018 and 2019, respectively. The loans contributed to interest receivable of RMB454 and RMB2,891 (US$415) as at December 31, 2018 and 2019, respectively.

iv)

The advances to employees represented interest-free advance held by the Group’s employees to cover expenses of hospital customers. The risk of loss is assessed prior to making the advances and is monitored on a regular basis by management. Historically, the Group has not experienced any loss of such advances.

v)

Receivables from disposal of medical equipment represented the consideration to be received from several hospitals, which the Group entered into termination contracts with and disposed all leasing equipment to.  

vi)

Tax refund represented the overpayment of tax that would be refund by Internal Revenue Service. The amount has been received subsequently in February 2020.